Theolytics
Transforming patients’ lives | Through world leading science | With a great team
Oxford, United Kingdom
31 employees
Series Unknown
Total: $50.40M
Biotechnology, Health and Wellness
General Information
Get notified when Theolytics moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Theolytics
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United Kingdom Market
Biotechnology
About Theolytics
Taxonomy: Oncolytic viral therapy, Phenotypic screening platform, Cancer treatment, Adenoviral therapy, Clinical stage biotechnology, Pipeline development, Solid tumors, Liquid tumors, Virology, Partnerships, Intravenous delivery, Patient population, Disease combat, Science innovation
Funding Rounds & Investors (4)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | •••••• | 6 |
|
17 Apr 2024 |
| Series A | •••••• | 4 |
|
25 Aug 2023 |
| Series A | •••••• | - | 07 Jan 2021 | |
| Seed Round | •••••• | - | 01 Dec 2017 |
Theolytics Alternatives & Competitors
A clinical stage biotech developing first-in-class cell therapies targeting solid and liquid tumors.
Genelux Corporation (NASDAQ: GNLX) is a late clinical-stage biotechnology company focused on improvi...
An oncology biotherapeutics company
FAQ About Theolytics
Don't just browse. Track.
Signal Tracker monitors Theolytics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.